Iron Triangle Partners’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-137,448
Closed -$27.9M 40
2025
Q3
$27.9M Sell
137,448
-52,552
-28% -$9.32M 3.97% 10
2025
Q2
$33.4M Sell
190,000
-19,454
-9% -$2.93M 5.14% 7
2025
Q1
$28.2M Buy
+209,454
New +$27.6M 4.44% 7
2024
Q4
Sell
-308,940
Closed -$51.3M 38
2024
Q3
$51.3M Buy
+308,940
New +$46.7M 7.11% 4
2021
Q4
Sell
-317,797
Closed -$21.1M 31
2021
Q3
$21.1M Sell
317,797
-166,208
-34% -$11.8M 3.03% 15
2021
Q2
$32.4M Buy
+484,005
New +$30M 3.34% 16

Other funds holding THC

Iron Triangle Partners's THC Position: Q4 2025 in Review

Iron Triangle Partners sold out of Tenet Healthcare (THC) in Q4 2025, closing a stake of 137,448 shares — an estimated $27.9M sold.

Iron Triangle Partners first reported a position in THC in Q2 2021 and held it in 6 quarters. The position peaked at $51.3M in Q3 2024. 705 funds tracked by Wall St. Rank hold THC as of Q4 2025.

  • Iron Triangle Partners reported no remaining Tenet Healthcare position as of Q4 2025 after selling out during the quarter.
  • Iron Triangle Partners sold 137,448 Tenet Healthcare shares in Q4 2025, an estimated $27.9M.
  • Iron Triangle Partners first reported a position in Tenet Healthcare in Q2 2021 and held it in 6 quarters.
  • Iron Triangle Partners's Tenet Healthcare position peaked at $51.3M in Q3 2024.
  • 705 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2025.

Based on Iron Triangle Partners's 13F filing for Q4 2025, filed 17 Feb 2026.